Response to COVID‐19 vaccination in patients on cancer therapy: Analysis in a SARS‐CoV‐2‐naïve population

Documenti analoghi

• Neoadjuvant Chemotherapy With Chemoradiotherapy for Patients With Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma—Retrospective Review From a Tertiary Care Hospital
  di: Avtaj Nerwal, et al.
  Pubblicazione: (2025)
• The clinical utility of autologous tumor lysate‐loaded dendritic cell vaccination for patients with glioma: A systematic review and meta‐analysis
  di: Mohammad Amin Habibi, et al.
  Pubblicazione: (2024)
• Real‐World Survival Outcomes of Patients With High PD‐L1 Advanced NSCLC Who Received Chemoimmunotherapy Versus Immunotherapy
  di: Junipearl Cheng, et al.
  Pubblicazione: (2025)
• PRIORITI: Phase 4 study of triptorelin or active surveillance in high‐risk prostate cancer
  di: Vsevolod Matveev, et al.
  Pubblicazione: (2024)
• Navigating Evidence Standards: Stakeholder Perspectives on External Controls and Randomization in Cancer Trials
  di: Sarah E. Heynemann, et al.
  Pubblicazione: (2026)